ATE271556T1 - Verbesserter chemischer prozess und eine pharmazeutische zubereitung - Google Patents
Verbesserter chemischer prozess und eine pharmazeutische zubereitungInfo
- Publication number
- ATE271556T1 ATE271556T1 AT99962610T AT99962610T ATE271556T1 AT E271556 T1 ATE271556 T1 AT E271556T1 AT 99962610 T AT99962610 T AT 99962610T AT 99962610 T AT99962610 T AT 99962610T AT E271556 T1 ATE271556 T1 AT E271556T1
- Authority
- AT
- Austria
- Prior art keywords
- manufacturing
- substituted sulphinyl
- compound
- formula
- adjusted
- Prior art date
Links
- 238000001311 chemical methods and process Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 159000000011 group IA salts Chemical class 0.000 abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 3
- 239000013543 active substance Substances 0.000 abstract 2
- 239000007900 aqueous suspension Substances 0.000 abstract 2
- 239000002552 dosage form Substances 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 239000003125 aqueous solvent Substances 0.000 abstract 1
- 239000012512 bulk drug substance Substances 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- 159000000003 magnesium salts Chemical class 0.000 abstract 1
- MQEUGMWHWPYFDD-UHFFFAOYSA-N magnesium;6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1h-benzimidazole Chemical class [Mg].N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C MQEUGMWHWPYFDD-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229940126409 proton pump inhibitor Drugs 0.000 abstract 1
- 239000000612 proton pump inhibitor Substances 0.000 abstract 1
- -1 sulphinyl compound Chemical class 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803953A SE9803953D0 (sv) | 1998-11-18 | 1998-11-18 | Improved chemical process |
| SE9803952A SE9803952D0 (sv) | 1998-11-18 | 1998-11-18 | Pharmaceutical formulation |
| PCT/SE1999/002093 WO2000028975A2 (en) | 1998-11-18 | 1999-11-15 | Improved chemical process and pharmaceutical formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE271556T1 true ATE271556T1 (de) | 2004-08-15 |
Family
ID=26663439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99962610T ATE271556T1 (de) | 1998-11-18 | 1999-11-15 | Verbesserter chemischer prozess und eine pharmazeutische zubereitung |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6403616B1 (https=) |
| EP (1) | EP1131316B1 (https=) |
| JP (1) | JP4610086B2 (https=) |
| KR (1) | KR100619200B1 (https=) |
| CN (1) | CN100503598C (https=) |
| AT (1) | ATE271556T1 (https=) |
| AU (1) | AU770633B2 (https=) |
| BR (1) | BR9915421A (https=) |
| CA (1) | CA2347981C (https=) |
| DE (1) | DE69918854T2 (https=) |
| DK (1) | DK1131316T3 (https=) |
| ES (1) | ES2222754T3 (https=) |
| HK (1) | HK1038920B (https=) |
| IL (2) | IL142629A0 (https=) |
| NO (1) | NO321275B1 (https=) |
| NZ (1) | NZ511169A (https=) |
| PT (1) | PT1131316E (https=) |
| WO (1) | WO2000028975A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
| US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| WO2005082888A1 (en) * | 2004-03-01 | 2005-09-09 | Milen Merkez Ilac Endustrisi A.S. | Process for the preparation of magnesium salt of omeprazole |
| US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8779175B2 (en) | 2004-10-25 | 2014-07-15 | Synthonics, Inc. | Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients |
| US20060141054A1 (en) | 2004-10-25 | 2006-06-29 | Thomas Piccariello | Metal coordinated compositions |
| US7799937B2 (en) | 2004-10-25 | 2010-09-21 | Synthonics, Inc. | Metal coordinated compositions |
| AU2007266574A1 (en) * | 2006-06-01 | 2007-12-06 | Dexcel Pharma Technologies Ltd. | Multiple unit pharmaceutical formulation |
| US20090280173A1 (en) * | 2008-05-09 | 2009-11-12 | Ishwar Chauhan | Multilayer Omeprazole Tablets |
| EP3372080A3 (en) | 2011-11-10 | 2018-10-17 | Rotam Agrochem International Co., Ltd | Herbicidal composition and method of using the same |
| WO2016174664A1 (en) | 2015-04-29 | 2016-11-03 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL76839A (en) * | 1984-10-31 | 1988-08-31 | Byk Gulden Lomberg Chem Fab | Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
| GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
| DE69127275T2 (de) * | 1991-06-21 | 1998-03-12 | Ilsan Ilac Ve Hammaddeleri San | Neues galenisches Verfahren für Omeprazol enthaltende Pellets |
| SE9301830D0 (sv) | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
| SE9302396D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | A novel compound form |
| SE9302395D0 (sv) | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
| TNSN95062A1 (fr) * | 1994-05-27 | 1996-02-06 | Astra Ab | Nouveaux derives dialkoxy-pyridinyle-benzimidazole |
| SE9402431D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
| US5945124A (en) * | 1995-07-05 | 1999-08-31 | Byk Gulden Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
| AUPN846496A0 (en) * | 1996-03-05 | 1996-03-28 | Research Laboratories Of Australia Pty Ltd | Electronic printing for display technology |
| SE508669C2 (sv) * | 1996-04-26 | 1998-10-26 | Astra Ab | Nytt förfarande |
| CN1134667C (zh) * | 1996-05-17 | 2004-01-14 | 福姆法克特公司 | 微电子弹性接触元件 |
| CN1128997C (zh) * | 2001-01-04 | 2003-11-26 | 中国科学院南京土壤研究所 | 一种吸力平板的制作方法 |
-
1999
- 1999-11-15 AT AT99962610T patent/ATE271556T1/de active
- 1999-11-15 NZ NZ511169A patent/NZ511169A/xx not_active IP Right Cessation
- 1999-11-15 AU AU19017/00A patent/AU770633B2/en not_active Ceased
- 1999-11-15 BR BR9915421-8A patent/BR9915421A/pt active Search and Examination
- 1999-11-15 EP EP99962610A patent/EP1131316B1/en not_active Expired - Lifetime
- 1999-11-15 PT PT99962610T patent/PT1131316E/pt unknown
- 1999-11-15 US US09/485,897 patent/US6403616B1/en not_active Expired - Lifetime
- 1999-11-15 HK HK02100464.5A patent/HK1038920B/en not_active IP Right Cessation
- 1999-11-15 CN CNB998133280A patent/CN100503598C/zh not_active Expired - Fee Related
- 1999-11-15 WO PCT/SE1999/002093 patent/WO2000028975A2/en not_active Ceased
- 1999-11-15 DK DK99962610T patent/DK1131316T3/da active
- 1999-11-15 JP JP2000582023A patent/JP4610086B2/ja not_active Expired - Fee Related
- 1999-11-15 IL IL14262999A patent/IL142629A0/xx active IP Right Grant
- 1999-11-15 CA CA2347981A patent/CA2347981C/en not_active Expired - Fee Related
- 1999-11-15 KR KR1020017006233A patent/KR100619200B1/ko not_active Expired - Fee Related
- 1999-11-15 ES ES99962610T patent/ES2222754T3/es not_active Expired - Lifetime
- 1999-11-15 DE DE69918854T patent/DE69918854T2/de not_active Expired - Lifetime
-
2001
- 2001-04-16 IL IL142629A patent/IL142629A/en not_active IP Right Cessation
- 2001-05-16 NO NO20012427A patent/NO321275B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO321275B1 (no) | 2006-04-10 |
| BR9915421A (pt) | 2001-08-07 |
| JP2002529497A (ja) | 2002-09-10 |
| NZ511169A (en) | 2003-06-30 |
| KR20010089474A (ko) | 2001-10-06 |
| CN100503598C (zh) | 2009-06-24 |
| EP1131316B1 (en) | 2004-07-21 |
| HK1038920B (en) | 2005-03-11 |
| AU770633B2 (en) | 2004-02-26 |
| CA2347981C (en) | 2010-05-04 |
| PT1131316E (pt) | 2004-10-29 |
| IL142629A0 (en) | 2002-03-10 |
| JP4610086B2 (ja) | 2011-01-12 |
| NO20012427D0 (no) | 2001-05-16 |
| NO20012427L (no) | 2001-07-09 |
| DE69918854D1 (de) | 2004-08-26 |
| IL142629A (en) | 2007-12-03 |
| US6403616B1 (en) | 2002-06-11 |
| WO2000028975A2 (en) | 2000-05-25 |
| WO2000028975A3 (en) | 2000-08-10 |
| CA2347981A1 (en) | 2000-05-25 |
| KR100619200B1 (ko) | 2006-09-05 |
| CN1326455A (zh) | 2001-12-12 |
| HK1038920A1 (en) | 2002-04-04 |
| DE69918854T2 (de) | 2005-07-21 |
| AU1901700A (en) | 2000-06-05 |
| EP1131316A2 (en) | 2001-09-12 |
| ES2222754T3 (es) | 2005-02-01 |
| DK1131316T3 (da) | 2004-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE271556T1 (de) | Verbesserter chemischer prozess und eine pharmazeutische zubereitung | |
| DE60003025T2 (de) | Arylsulfonyle als faktor xa inhibitoren | |
| US11253861B2 (en) | Preparation of modified cellulose and its derivatives | |
| NZ527585A (en) | Tablets quickly disintegrated in oral cavity | |
| MY131971A (en) | Formulation of substituted benzimidazoles | |
| US5420137A (en) | Amonafide salts | |
| JP2002529497A5 (https=) | ||
| PT2405910E (pt) | Derivados de rosuvastatina e atorvastatina | |
| RU2009103818A (ru) | Водная лекарственная композиция 4-[(4-карбоксибутил)-{2-[(4-фенетилбензил)окси)-фенетил}амино)метил)-бензойной кислоты | |
| AR029002A1 (es) | Proceso para preparar compuestos de acidos quinolin-2-carboxilicos y de sus sales farmaceuticamente aceptables | |
| SU1053751A3 (ru) | Способ получени водорастворимых солей 1,1-диоксида @ -(2-пиридил)-2-метил-4-окси-2 @ -1,2-бензтиазин-3-карбоксамида | |
| NZ505080A (en) | Pharmaceutical formulations containing a compound having an amidine group stabilized by an acid | |
| EP2264025B1 (en) | Method for producing lansoprazole | |
| FR2318636A1 (fr) | Procede d'obtention de preparations pharmaceutiques stables pour usage oral, contenant des derives d'homopyrimidazole | |
| TH18739A (th) | ริสเพอริโดนพาโมเอท | |
| JP2011157325A (ja) | ノイラミニダーゼに対する酵素阻害剤 | |
| SU1189876A1 (ru) | Дезинфицирующее средство "дезнор | |
| JPS6153267A (ja) | 酸化および湿気に抵抗性のプロカテロ−ル誘導体およびその製法 | |
| GB1188959A (en) | 2-Substituted Pyridines as Anthelmintic Agents | |
| GB1156854A (en) | Lactones of Optically Active Heterocyclic Amino Acids and Process for the Preparation thereof | |
| TH80301A (th) | สารประกอบทางเคมี | |
| TH81540A (th) | สารผสมทางเภสัชกรรมของวินฟลูนีนสำหรับการให้ยาโดยทางที่ไม่ผ่านทางเดินอาหาร, กระบวนการเตรียม และการใช้สารผสมนี้ | |
| TH34905A (th) | กระบวนการเตรียมตัวต่อต้าน nmda | |
| GB1388088A (en) | N-b-2-acetyl-4-chloro-phenoxy-ethyl-n,n-dimethyl-n-benzyl- ammonium-p-chlorobenzene sulphonate method for preparing same and medicinal preparation based thereon | |
| FR2597341A1 (fr) | Solution pharmaceutique contenant de chelates de l-3,4-dihydroxyphenyl-alpha-methylalanine et procede pour la preparation de celle-ci. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1131316 Country of ref document: EP |